Overview
Dedicated to rheumatologists and advanced practice professionals caring for the pediatric population, the Pediatric Rheumatology Symposium (PRSYM) carries on the educational tradition of previous winter meetings held in Keystone, Colorado, offering the same quality experience. This unique setting provides opportunities for speakers and attendees to gather informally, share experiences and take full advantage of the family recreational activities and cultural amenities.
The PRSYM program provides a greater number of plenary sessions, ample opportunities for abstract presentations and early morning poster sessions held in conjunction with breakfast. The opening reception will also feature poster sessions. This newly designed program has been formatted with a generous timeframe for interaction between presenters, speakers, colleagues and friends.
Target Audience
This course is designed for rheumatologists, physicians and healthcare providers who care for patients with pediatric rheumatic diseases and clinical investigators, physician-scientists and researchers interested or engaged in research in the field of pediatric rheumatic diseases.
LEARNING OBJECTIVES
Upon completion of this program, participants should be able to:
- discuss the most up-to-date evidence-based treatment approaches in the management of pediatric rheumatic diseases
- discuss the most recent scientific and clinical advances regarding the pathogenesis of pediatric rheumatic diseases, including new targets for therapy
NEEDS ASSESSMENT
Recent years have seen critical advances in the understanding, assessment and treatment of many pediatric rheumatic diseases. Previously considered a rarity with a significant degree of morbidity, rheumatic diseases in children have long been difficult to diagnose and even more challenging to treat. Innovative research and a highly focused approach in clinical trials have established a much needed foundation for realizing progress within the field. Pediatric rheumatic diseases are now recognized with an increasing frequency, leading to earlier diagnoses and improved clinical care.
PRSYM offers a unique forum for physicians and other health care providers interested in pediatric rheumatology to explore findings from recent research studies, discuss the latest scientific information, and to hear from thought leaders and distinguished speakers on a variety of topics.
The scientific program will include lectures, table topics, oral abstract and poster presentations in clinical, basic science and educational training areas, allowing participants to share innovative ideas for improved outcomes in the pediatric population.
CME
Physicians
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Rheumatology designates the Pediatric Rheumatology Symposium for 21.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Health Professionals
Certificates of attendance/participation for non-physicians are offered. The Association of Rheumatology Health Professionals designates the Pediatric Rheumatology Symposium for 21.50 hours of participation.
Copyright Material Policy
The Pediatric Rheumatology Symposium is not a public event. Programs presented at the symposium are for the education of attendees and purchasers of recorded presentations as authorized by the ACR. The information and materials displayed and presented during this symposium are the property of the American College of Rheumatology and the presenter and cannot be photographed, copied, photocopied, transformed to electronic format, reproduced, or distributed without written permission of the American College of Rheumatology and the presenter. Any use of the program content for commercial purposes, which includes, but is not limited to oral presentations, audiovisual materials used by speakers, and program handouts without the written consent of the ACR is prohibited. This policy applies before, during and after the symposium. The ACR will enforce its intellectual property rights and penalize those who infringe upon it. The names, insignias, logos and acronyms of the ACR, the ARHP and the REF are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the express written permission of the American College of Rheumatology.
ACR DISCLOSURE POLICY
It is the policy of the American College of Rheumatology to ensure that its CME activities are independent and free of commercial bias. To ensure content objectivity and balance, and guarantee that the content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control the content must disclose all relevant financial relationships with any commercial interest if the relationship is financial and occurred within the past 12 months. If there are relationships that create a conflict of interest, these must be resolved by the Planning Committee chair in consultation with the ACR's Committee on Education designee(s) prior to the participation of the individual in the development or presentation of CME content.
Any individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a presenter, or an author of a CME activity, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity.
Disclosures will be published prior to the start of the symposium.
Disclaimer: Disclosure information is considered accurate at the time of publishing. As needed, presenters will provide updated disclosure information to learners prior to content presentation.
Abstracts
The 2011 Pediatric Rheumatology Symposium abstract Supplement iss now available for viewing.
Syllabus
Access the syllabus from the 2011 Pediatric Rheumatology Symposium (requires password).
Exhibitors
2011 Pediatric Rheumatology Symposium Tabletop Display Exhibitors:
Abbott Laboratories
AccentHealth
Bristol-Myers Squibb Company
Genentech, Inc.
Iroko Pharmaceuticals
National MPS Society
Novartis Pharmaceuticals Corporation
